This week, BioPharmaDispatch is using a series to highlight red flags in the Health Technology Assessment Review report, each contributing to undermining access to medicines and other therapeutic interventions. …
The HTA Review report - 'Red Flag' number one of five
September 16, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
A hearing that provided more evidence of the need for meaningful change
October 29, 2026 - - Latest News -
Biotech sector warns R&D tax changes could drive clinical trials offshore
October 28, 2026 - - Latest News -
Rebates and net spend are the major PBS story of the past decade
October 28, 2026 - - Latest News -
Astellas bets up to US$1.34 billion on Melbourne startup's cancer candidate
October 28, 2026 - - Latest News -
Managing an agreement negotiation as a 'prisoner of circumstance'
October 28, 2026 - - Latest News -
Lung scarring killing 11 Australians a day, with one in five cases traced to work
October 28, 2026 - - Latest News -
The stakes are very high on access in a contested budget environment
October 28, 2026 - - Latest News